07:44 AM EST, 11/05/2025 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported fiscal Q3 non-GAAP earnings Wednesday of $2.43 per diluted share, down from $2.59 a year earlier.

Analysts polled by FactSet expected $2.34.

Total revenue for the quarter ended Sept. 27 was $1 billion, down from $1.01 billion a year earlier.

Analysts surveyed by FactSet expected $990.8 million.

The company said it now expects fiscal 2025 non-GAAP EPS to range from $10.10 to $10.30, compared with the previous guidance of $9.90 to $10.30. Analysts surveyed by FactSet expect $10.20.

Charles River also updated its fiscal 2025 revenue growth guidance and now expects a decrease of 0.5% to 1.5%, compared with the previous guidance of a 0.5% to 2.5% decline. Analysts polled by FactSet expect $3.99 billion.